◈ Nootpedia
Extended Research →
Verdict, decision matrix, deep dives, sourcing notes & full sources

Testosterone Enanthate

Emerging

Bioidentical testosterone in oil depot — gold-standard TRT for documented hypogonadism, but a HPG-suppressing supraphysiologic hammer in… | AAS · Oil injectable

Aliases (5)
Test-E · Delatestryl · Xyosted · Testoviron Depot · T-E
TYPICAL DOSE
TRT (clinically replacement, hypogonadism only):
ROUTE
Intramuscular injection (oil)
CYCLE
8-12 week cycle + PCT
STORAGE
Room temp; protect from light
✎
Did you know? You can suggest edits to improve this compound's information.
Submitted via email — no account required.
Suggest an edit
▸ Vial inspection & sterile draw AAS oil

AAS oil arrives pre-suspended in carrier oil — no BAC water needed. Inspect for clarity, color, and crashed compound (cold storage can crystallize). Warm vial in palm or under hot tap before draw.

Steps
  1. 1 Wipe vial stopper with isopropyl alcohol.
  2. 2 Warm vial 30-60s in palm if oil is cold/cloudy.
  3. 3 Draw with 18g needle into 22-25g pin barrel for IM, or 27-29g for sub-Q.
  4. 4 Tap out air bubbles, expel a small drop, then inject at chosen site.
Open dose calculator for Testosterone Enanthate
▸ Cycle structure & PCT AAS
Ester
enanthate
Frequency
2x/week
PCT
Required
Phase 1 — On cycle

Ramp dose over week 1, hold steady through cycle weeks. Track baseline labs (TT/FT/E2/SHBG/HCT/lipids/LFTs) at week 0; recheck at week 4 and end-of-cycle.

Phase 2 — Bridge / cease

On the last dose, the ester clears over its half-life window (enanthate = est. 7 days). PCT begins after the active compound has cleared.

Phase 3 — PCT (post-cycle therapy)

Standard PCT is enclomiphene 12.5-25 mg/day or clomid 50/50/25/25 over 4 weeks (or nolvadex 20/20/10/10). HCG bridge optional during cycle to preserve testicular volume + faster restart. Bloodwork at PCT week 4 + 8 to confirm HPG axis recovery (LH, FSH, TT back to baseline).

▸ Overview TL;DR

Bioidentical testosterone in oil depot — gold-standard TRT for documented hypogonadism, but a HPG-suppressing supraphysiologic hammer in healthy 20yo males. SKIP-AT-20 unless June 2026 bloodwork shows real low-T pathology. The "bioidentical" framing is technically true but irrelevant — exogenous administration shuts down endogenous production regardless of molecule.

▸ Mechanism of action
  • Molecule: Identical to endogenous testosterone, esterified at the 17β-hydroxyl with enanthoic (heptanoic) acid. The ester slows release from the IM oil depot; enzymatic cleavage in plasma liberates free testosterone.
  • Half-life: 4-7 days (mean ~4.5d). Steady state in ~5 half-lives → ~3-4 weeks. Standard TRT injection cadence: every 5-7 days; bodybuilder protocols often 2x/week to flatten peak-trough.
  • Receptor activity:
    • AR (androgen receptor): Full agonist; drives anabolic protein synthesis, RBC production (via EPO), libido, secondary sex characteristics, behavior.
    • GR cross-talk: Modest anti-glucocorticoid effect at supraphysiologic levels — partial explanation for "anti-cortisol" subjective effects.
    • 5α-reductase → DHT: Potentiates effect in skin (acne, MPB), prostate, scalp.
    • Aromatase → estradiol (E2): ~0.3% conversion; unmanaged supraphysiologic T → high E2 → gyno, water retention, emotional lability. AI (anastrozole) often co-administered in BB protocols; rarely needed at TRT doses.
  • HPG suppression: Negative feedback at hypothalamus (GnRH↓) and pituitary (LH↓, FSH↓) → testicular atrophy + spermatogenesis collapse. Recovery time after long cycles: 3-18 months, sometimes never.
▸ Pharmacokinetics Approximate
t½: 4-7 days (mean ~4
100% 50% 0% 0 7d 14d 2.9w 3.9w t½ Peak

Approximate decay curve drawn from the half-life mention(s) in the source notes. Real PK data not yet ingested per compound.

▸Research protocols2 protocols
GoalDoseFrequencySoloCycle
TRT (clinically replacement, hypogonadism only):100-200 mg IM/SubQ once weekly OR 50-100 mg twice weekly to flatten levelsonce weekly——
Performance / supraphysiologic (NOT recommended for Dylan):300-600 mg/wk × 10-16 weeks + AI + PCT (SERM)——10-16 week

Auto-extracted from dosing notes. For full context including caveats and Dylan-specific protocols, see the Dosing protocols section.

▸Quality indicators5 checks
✓
Clear oil
Yellow tint is normal (carrier oil); cloudiness or sediment is not.
✓
No particulates
Hold the vial up to light. Floaters mean discard, not filter.
!
Color matches ester
Test E is light yellow; Tren A is amber. Off-color suggests under-dosing or wrong compound.
✓
Sterile draw technique
Always swab vial top, fresh needle for draw, fresh needle for injection.
!
Crashed gear is recoverable
Holosteric carrier crashes when cold. Warm to body temp; if still cloudy, discard.
▸ What to expect From notes
  1. 1
    Onset
    (TRT 100-200 mg/wk): Subtle. Energy, morning erections, sleep quality improve over 2-6 weeks. Body comp shi…
  2. 2
    Onset
    (supraphysiologic 400-600 mg/wk): Within 1-2 weeks: noticeable libido + drive surge, training aggression, f…
  3. 3
    Peak
    Plateau by ~week 4-6. Sustained anabolic effect persists for the cycle duration.
  4. 4
    Taper
    / post-cycle: Without PCT, crash in ~2-3 weeks post-last-injection. Profound fatigue, libido collapse, depr…
▸ Side effects + safety
  • Common (>10% users):
    • Testicular atrophy (universal at suppressive doses)
    • Decreased spermatogenesis / oligospermia / azoospermia
    • Acne, oily skin
    • Water retention / edema (E2-mediated)
    • Increased hematocrit / hemoglobin
    • Injection site soreness (PIP — post-injection pain)
  • Less common (1-10%):
    • Gynecomastia (E2-driven, especially without AI in supra dosing)
    • Mood lability / irritability / aggression ("roid rage" — variable, dose-dependent)
    • Sleep apnea worsening
    • Accelerated androgenic alopecia (in genetically susceptible)
    • Lipid panel deterioration (HDL ↓, LDL/ApoB ↑)
    • Suppressed HDL particularly with oral 17α-alkylated stacks; less severe but real with injectables
  • Rare-serious (<1% but worth knowing):
    • Polycythemia → thromboembolic risk (DVT, PE, stroke). Phlebotomy/dose reduction if Hct >54%.
    • Cardiomyopathy / LVH at chronic supraphysiologic exposure (years).
    • Permanent fertility loss (reported even after PCT in some cases).
    • Prostate hypertrophy / unmasking of subclinical prostate cancer.
    • Sterile abscess at injection site (poor technique / contaminated gear).
    • Hepatic effects: minimal with injectables (vs oral 17α-alkylated like methyltestosterone).
  • Specific watch periods:
    • First 8-12 weeks: monitor hematocrit, E2, libido response, mood.
    • 3 months in: full lipid + comprehensive panel.
    • Annually: PSA (if >40 or family hx), DRE per AUA.
▸Interactions7 compounds
  • Anastrozole / aromatase inhibitor:Synergistic
    Manages E2 at supraphysiologic doses. Rarely needed at TRT doses.
  • hCG (250-500 IU 2x/wk):Synergistic
    Maintains testicular volume + intratesticular T for fertility preservation in younger TRT patients.
  • Finasteride (caveat):Synergistic
    Used for hair preservation but blocks 5α-reductase → may attenuate anabolic effect in muscle (controversial) and has its own neuroendocrine side effect profi…
  • methyltestosterone:Avoid
    Hepatotoxic 17α-alkylated oral; redundant + dangerous combo.
  • oxandrolone (Anavar):Avoid
    Less hepatotoxic but still 17α-alkylated; HDL crash risk compounds.
  • Other AAS in young men (Tren, Deca, etc.):Avoid
    Each adds specific harms (Tren = neuro/CV/sleep; Deca = prolactin + "deca dick" + much longer suppression).
  • Stimulants at high dose:Avoid
    Compounds CV strain (HR + BP + Hct).
Was this helpful?
Your feedback shapes what we research deeper.
Continue: Extended Research →
Our verdict, decision matrix, deep dives, controversies, sources

Related compounds

Cross-referenced from Testosterone Enanthate
Enclomiphene Citrate
SKIP-FOR-NOW
Selective Estrogen Receptor Modulator (SERM) — trans-isomer of clomiphene citrate
MEDIUM
Methyltestosterone
SKIP-PERMANENT
Anabolic-androgenic steroid (AAS) — oral C17α-alkylated testosterone derivative
HIGH
Oxandrolone
SKIP-FOR-NOW
Anabolic-Androgenic Steroid (AAS) — 17α-alkylated oral DHT (dihydrotestosterone) derivative; non-aromatizable; modest anabolic / low androgenic synthetic progestogen-free testosterone analog
HIGH
Boldenone Undecylenate
SKIP-FOR-NOW
Anabolic-androgenic steroid (AAS) — testosterone derivative with an extra C1-C2 double bond. Esterified at 17β-OH with undecylenate (an 11-carbon unsaturated fatty acid ester). Veterinary product, originally developed by Ciba in the 1950s as a long-acting testosterone alternative; later approved for veterinary equine use as Equipoise (Squibb / Fort Dodge Animal Health). No human FDA approval ever.
MEDIUM
DHEA (Dehydroepiandrosterone)
SKIP-FOR-NOW
Adrenal steroid hormone / sex steroid precursor
MEDIUM
Methenolone
SKIP-FOR-NOW
Anabolic-androgenic steroid (AAS) — DHT-derivative, 1-methylated
MEDIUM
Trenbolone
SKIP-PERMANENT
19-nor anabolic-androgenic steroid (veterinary)
HIGH
Trestolone
SKIP-PERMANENT
Anabolic-androgenic steroid (19-nor, 7α-methyl)
HIGH

More in AAS · Oil injectable

7 compounds in bucket
Boldenone Undecylenate
SKIP-FOR-NOW
Anabolic-androgenic steroid (AAS) — testosterone derivative with an extra C1-C2 double bond. Esterified at 17β-OH with undecylenate (an 11-carbon unsaturated fatty acid ester). Veterinary product, originally developed by Ciba in the 1950s as a long-acting testosterone alternative; later approved for veterinary equine use as Equipoise (Squibb / Fort Dodge Animal Health). No human FDA approval ever.
MEDIUM
Masteron Enanthate
SKIP-FOR-NOW
Anabolic-Androgenic Steroid (AAS) — DHT-derivative; 2α-methylated; non-aromatizable; long-ester injectable; cosmetic / "hardening" archetype
MEDIUM
Methenolone
SKIP-FOR-NOW
Anabolic-androgenic steroid (AAS) — DHT-derivative, 1-methylated
MEDIUM
Testosterone Cypionate
SKIP-FOR-NOW
Endogenous androgen / anabolic-androgenic steroid (bioidentical testosterone with cypionate ester) — long-acting injectable
HIGH
Trenbolone
SKIP-PERMANENT
19-nor anabolic-androgenic steroid (veterinary)
HIGH
Trenbolone Enanthate
SKIP-PERMANENT
19-nor anabolic-androgenic steroid (long-ester injectable; veterinary parent compound)
HIGH